nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
80 A carboxypeptidase inhibitor markedly improves the potency of tPA in-vivo
|
|
|
1998 |
|
S1 |
p. 29- 1 p. |
artikel |
2 |
206 A clot — target anticoagulant
|
|
|
1998 |
|
S1 |
p. 75- 1 p. |
artikel |
3 |
131 Activation of procarboxypeptidase U, an enzyme involved in the regulation of fibrinolysis
|
|
|
1998 |
|
S1 |
p. 46- 1 p. |
artikel |
4 |
198 A de novo spontaneous point mutation found in a Brazilian patient with antithrombin deficiency
|
|
|
1998 |
|
S1 |
p. 73- 1 p. |
artikel |
5 |
100 Adhesion and integrin signaling in the human kidney epithelial cell line TCL-598 are modulated by the urokinase receptor in a matrix dependent fashion
|
|
|
1998 |
|
S1 |
p. 36- 1 p. |
artikel |
6 |
77 Affinity of lipoprotein(a) for cell and fibrin is modulated by apo(a) size
|
|
|
1998 |
|
S1 |
p. 28- 1 p. |
artikel |
7 |
50 A 30,000 g/mol protein involved in plasminogen activation in the dextran sulphate euglobulin fraction of human plasma depleted in both t-PA and u-PA
|
|
|
1998 |
|
S1 |
p. 19- 1 p. |
artikel |
8 |
259 All-trans retinoic acid (ATRA) inhibits the fibrinolytic capacity of blood mononuclear cells
|
|
|
1998 |
|
S1 |
p. 96- 1 p. |
artikel |
9 |
138 A method for determination of t-PA activity in rat
|
|
|
1998 |
|
S1 |
p. 49- 1 p. |
artikel |
10 |
97 A model to explain the mechanism of stimulation of tPA activity by cell surface receptors
|
|
|
1998 |
|
S1 |
p. 35- 1 p. |
artikel |
11 |
12 A monoclonal antibody inducing the substrate form of PAI-1 has antithrombotic activity in rat models of venous and arterial thrombosis
|
|
|
1998 |
|
S1 |
p. 6- 1 p. |
artikel |
12 |
68 A monoclonal antibody (MAB) to fibrin. Delineation of the epitope on the COOH terminal of the Aα-chain and its use in a soluble fibrin assay
|
|
|
1998 |
|
S1 |
p. 25- 1 p. |
artikel |
13 |
40 A mutant of plasminogen activator inhibitor type-2 (PAI-2) that is less prone to form loop-sheet polymers
|
|
|
1998 |
|
S1 |
p. 16- 1 p. |
artikel |
14 |
74 Analysis of fibrin degradation products by multi-angle laser light scattering: A model for fibrin degradation
|
|
|
1998 |
|
S1 |
p. 27- 1 p. |
artikel |
15 |
142 Analytical evaluation of four D-dimer tests
|
|
|
1998 |
|
S1 |
p. 50- 1 p. |
artikel |
16 |
37 An ester bond linking a fragment of the serine proteinase uPA to its serpin inhibitor PAI-1
|
|
|
1998 |
|
S1 |
p. 15- 1 p. |
artikel |
17 |
72 A new highly sensitive rapid sandwich ELISA assay for the determination of blood coagulation factor XIII in human plasma
|
|
|
1998 |
|
S1 |
p. 26- 1 p. |
artikel |
18 |
53 A new mutation (Val384Met) in the human plasmin inhibitor gene associated with plasmin inhibitor deficiency and bleeding tendency
|
|
|
1998 |
|
S1 |
p. 20- 1 p. |
artikel |
19 |
69 A new test for measuring soluble fibrin in plasma with a high predictive value for thrombotic disorders
|
|
|
1998 |
|
S1 |
p. 25- 1 p. |
artikel |
20 |
252 Angiostatin fragments in urine from patients with malignant disease
|
|
|
1998 |
|
S1 |
p. 93- 1 p. |
artikel |
21 |
168 Anticardiolipin antibodies are associated with monocytes, metabolic and fibrinolytic parameters in young women with a history of myocardial infarction
|
|
|
1998 |
|
S1 |
p. 60- 1 p. |
artikel |
22 |
130 Antifibrinolytic versus profibrinolytic functions of histidine-rich glycoprotein
|
|
|
1998 |
|
S1 |
p. 46- 1 p. |
artikel |
23 |
6 Antigenic modulation of recombinant staphylokinase by comprehensive site-directed mutagenesis
|
|
|
1998 |
|
S1 |
p. 4- 1 p. |
artikel |
24 |
164 Antigen plasma levels of total and free tissue factor pathway inhibitor in hypercholesterolemia
|
|
|
1998 |
|
S1 |
p. 58- 1 p. |
artikel |
25 |
143 Antiplasmin and plasminogen on STA and STA Compact, evaluated
|
|
|
1998 |
|
S1 |
p. 51- 1 p. |
artikel |
26 |
169 Antithrombin and thrombolytic agents does not prevent platelet activation in heparin-induced thrombocytopenic syndromes
|
|
|
1998 |
|
S1 |
p. 61- 1 p. |
artikel |
27 |
8 Antithrombin prevents endotoxin-induced hypotension in rats by inhibiting excess production of nitric oxide
|
|
|
1998 |
|
S1 |
p. 5- 1 p. |
artikel |
28 |
Antithrombotic treatment for the preservation and enhancement of myocardial perfusion in chronic coronary artery disease
|
Leschke, M. |
|
1997 |
|
S1 |
p. 119-123 5 p. |
artikel |
29 |
115 APC resistance and fibrinolysis abnormalities in thrombophilic patients
|
|
|
1998 |
|
S1 |
p. 41- 1 p. |
artikel |
30 |
19 Associations of PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction. The PRIME study
|
|
|
1998 |
|
S1 |
p. 9- 1 p. |
artikel |
31 |
Atherosclerosis, thrombosis and inflammation: a problem of linkage
|
Tracy, R.P. |
|
1997 |
|
S1 |
p. 137-141 5 p. |
artikel |
32 |
73 Atomic force microscopy of fibrin networks and plasma clots during fibrinolysis
|
|
|
1998 |
|
S1 |
p. 27- 1 p. |
artikel |
33 |
Author index
|
|
|
1998 |
|
S1 |
p. 99-104 6 p. |
artikel |
34 |
140 Auto-Dimer, a new method for the measurement of D-dimer
|
|
|
1998 |
|
S1 |
p. 50- 1 p. |
artikel |
35 |
31 Basic fibroblast growth factor, urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 in lung cancer cells
|
|
|
1998 |
|
S1 |
p. 13- 1 p. |
artikel |
36 |
Bezafibrate following acute myocardial infarction: important findings from the bezafibrate coronary atherosclerosis intervention trial
|
Nilsson, J. |
|
1997 |
|
S1 |
p. 159-162 4 p. |
artikel |
37 |
2 cDNA and gene structure of rat plasminogen
|
|
|
1998 |
|
S1 |
p. 3- 1 p. |
artikel |
38 |
184 Cellular degradation of free and PAI-1-bound t-PA. Requirement for a co-receptor?
|
|
|
1998 |
|
S1 |
p. 67- 1 p. |
artikel |
39 |
193 Cellular localization of urokinase-type plasminogen activator, its inhibitors and their mRNAs in breast cancer tissues
|
|
|
1998 |
|
S1 |
p. 70- 1 p. |
artikel |
40 |
240 Changes in PAI-1, factor VII and fibrinogen by hormone replacement therapy are independent of promoter polymorphisms
|
|
|
1998 |
|
S1 |
p. 89- 1 p. |
artikel |
41 |
202 Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation
|
|
|
1998 |
|
S1 |
p. 74- 1 p. |
artikel |
42 |
183 Characterization of plasminogen receptor expression on NB4 promyelocytic cells
|
|
|
1998 |
|
S1 |
p. 67- 1 p. |
artikel |
43 |
197 Characterization of the binding of a pentapeptide to plasminogen activator inhibitor -1
|
|
|
1998 |
|
S1 |
p. 72- 1 p. |
artikel |
44 |
25 Characterization of the gene encoding human TAFI
|
|
|
1998 |
|
S1 |
p. 11- 1 p. |
artikel |
45 |
172 Climax and hormonal substitute therapy (HST)
|
|
|
1998 |
|
S1 |
p. 62- 1 p. |
artikel |
46 |
212 Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using HPLC and functional methods
|
|
|
1998 |
|
S1 |
p. 78- 1 p. |
artikel |
47 |
180 Clonning and expression of a new recombinant staphylokinase variant
|
|
|
1998 |
|
S1 |
p. 65- 1 p. |
artikel |
48 |
176 Coagulation activation markers in the diagnosis of deep vein thrombosis following total hip replacement
|
|
|
1998 |
|
S1 |
p. 63- 1 p. |
artikel |
49 |
243 Combined heterozygous deficiency of factor V and plasminogen in the same kindred
|
|
|
1998 |
|
S1 |
p. 90- 1 p. |
artikel |
50 |
126 Comparision the influence of different alpha adrenoreceptor antagonists on the fibrinolysis system
|
|
|
1998 |
|
S1 |
p. 45- 1 p. |
artikel |
51 |
123 Comparison of Actilyse and Reteplase by lysine binding and enzyme behaviour
|
|
|
1998 |
|
S1 |
p. 43- 1 p. |
artikel |
52 |
137 Comparison of a new rapid bedside assay for t-PA with a commercially available ELISA: Possible importance of t-PA antigen determination during thrombolytic therapy for predicition of outcome
|
|
|
1998 |
|
S1 |
p. 49- 1 p. |
artikel |
53 |
211 Comparison of tests for the measurement of C-reactive protein in the low range
|
|
|
1998 |
|
S1 |
p. 77- 1 p. |
artikel |
54 |
235 Comparison of the biological activities of chitosan polysulphate, unfractionated heparin and mixture of this substances after intravenous application
|
|
|
1998 |
|
S1 |
p. 87- 1 p. |
artikel |
55 |
26 Comparison of the structures of thrombomodulin required for the activation of protein C and TAFI
|
|
|
1998 |
|
S1 |
p. 11- 1 p. |
artikel |
56 |
196 Complex-formation of PAI-1 with tPA. Findings supporting full insertion of reactive-centre loop into β-sheet A
|
|
|
1998 |
|
S1 |
p. 71- 1 p. |
artikel |
57 |
Coronary artery disease and inflammation: reflection of underlying disease or repetitive ischemia
|
Liuzzo, G. |
|
1997 |
|
S1 |
p. 155-157 3 p. |
artikel |
58 |
92 Corticosteroids and insulin affect PAI-1 synthesis by human adipose tissue
|
|
|
1998 |
|
S1 |
p. 33- 1 p. |
artikel |
59 |
C-reactive protein and cardiovascular disease
|
Haverkate, F. |
|
1997 |
|
S1 |
p. 133-134 2 p. |
artikel |
60 |
4 Crystal structure of TSV-PA: A new plasminogen activator from snake venom
|
|
|
1998 |
|
S1 |
p. 4- 1 p. |
artikel |
61 |
66 Cyclic nucleotide regulation of plasminogen activator-inhibitor mRNA stability in rat hepatoma cells: identification of cis-acting sequences
|
|
|
1998 |
|
S1 |
p. 24- 1 p. |
artikel |
62 |
104 Detection of a PAI-1 gene allele variant possibly associated with decreased plasma levels of PAI-1 in four patients with bleeding tendency
|
|
|
1998 |
|
S1 |
p. 37- 1 p. |
artikel |
63 |
213 Detection of impaired platelet function during thrombolysis by PFA-100 platelet function analyzer
|
|
|
1998 |
|
S1 |
p. 78- 1 p. |
artikel |
64 |
257 Detection of tPA in human and mouse mast cells
|
|
|
1998 |
|
S1 |
p. 95- 1 p. |
artikel |
65 |
148 Disseminated intravascular coagulation, fibrinolysis-and proteolysis-syndrome (DIC-F-P-S) in two patients (PTS) with purulent cholangitis or portal sepsis, complicated with acute hepatic failure (AHF). Benefit from therapy with plasma derivates (PD) (AT IIIc, FFP)
|
|
|
1998 |
|
S1 |
p. 53- 1 p. |
artikel |
66 |
179 Does exact indication prevent hemorrhagic complications using streptokinase in acute ischemic stroke?
|
|
|
1998 |
|
S1 |
p. 65- 1 p. |
artikel |
67 |
17 Donor-Donor energy migration (DDEM) for determining intramolecular distances in latent plasminogen activator inhibitor type 1 (PAI-1)
|
|
|
1998 |
|
S1 |
p. 8- 1 p. |
artikel |
68 |
157 Effect of a low osmolality nonionic contrast medium on thrombin generation and fibrinolysis in patients subjected to coronary angiography
|
|
|
1998 |
|
S1 |
p. 56- 1 p. |
artikel |
69 |
129 Effect of arginines 320 and 330 of TAFI on the thermal stability of the enzyme — a thermodynamic interpretation
|
|
|
1998 |
|
S1 |
p. 46- 1 p. |
artikel |
70 |
112 Effect of heparin and hirudin on endotoxin-induced PAI-1 mRNA expression by human umbilical vein endothelial cells
|
|
|
1998 |
|
S1 |
p. 40- 1 p. |
artikel |
71 |
59 Effect of intravenous defibrotide treatment on soluble P-selectin, soluble thrombomodulin and PAI-1 levels
|
|
|
1998 |
|
S1 |
p. 22- 1 p. |
artikel |
72 |
28 Effect of TAFI activation on clot lysis by pharmacological concentrations of t-PA
|
|
|
1998 |
|
S1 |
p. 12- 1 p. |
artikel |
73 |
9 Effect of unfractionated heparin and a heparin pentasaccharide on the thrombolytic process in an experimental model in rabbits
|
|
|
1998 |
|
S1 |
p. 5- 1 p. |
artikel |
74 |
227 Effects of recombinant human erytropoietin (rHuEPO) on the fibrinolytic system in peritoneal dialysis (PD) patients
|
|
|
1998 |
|
S1 |
p. 84- 1 p. |
artikel |
75 |
224 Elevated PAI-1 and F1.2 levels in children with Escherichia coli O157:H7 related hemolytic uremic syndrome
|
|
|
1998 |
|
S1 |
p. 83- 1 p. |
artikel |
76 |
Endogenous fibrinolytic function and risks of future myocardial infarction and stroke: observations from the Physicians' Health Study
|
Ridker, P.M. |
|
1997 |
|
S1 |
p. 55-59 5 p. |
artikel |
77 |
76 Enhanced fibrinolytic capacity of α2-antiplasmin-deficient mice
|
|
|
1998 |
|
S1 |
p. 28- 1 p. |
artikel |
78 |
18 Evaluation of the mechanism of inactivation of plasminogen activator inhibitor-1 by monoclonal antibodies using a stable variant
|
|
|
1998 |
|
S1 |
p. 8- 1 p. |
artikel |
79 |
Experiments on the risk factor role of fibrinogen
|
Born, G.V.R. |
|
1997 |
|
S1 |
p. 9-12 4 p. |
artikel |
80 |
44 Expression of PAI-1 in normal and atherosclerotic vessels in an experimental model of angioplasty in pigs
|
|
|
1998 |
|
S1 |
p. 17- 1 p. |
artikel |
81 |
118 Expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation
|
|
|
1998 |
|
S1 |
p. 42- 1 p. |
artikel |
82 |
36 Expression of plasminogen-related gene B varies among normal tissues and increases in cancer tissues
|
|
|
1998 |
|
S1 |
p. 14- 1 p. |
artikel |
83 |
182 Expression of prolebetase from Vipera lebetina by baculovirus system. Plasminogen activating activity of SF-9 cell lysates
|
|
|
1998 |
|
S1 |
p. 66- 1 p. |
artikel |
84 |
165 Factor VIIa, plasminogen activator inhibitor-1, thrombomodulin and vWF levels in patients with arterial disease and patients with risk factors for arterial disease
|
|
|
1998 |
|
S1 |
p. 59- 1 p. |
artikel |
85 |
219 Failure of antiplatelet effectiveness of low-dose ASA in essential thrombocytaemia
|
|
|
1998 |
|
S1 |
p. 81- 1 p. |
artikel |
86 |
20 Fibrin D-dimer, C-reactive protein and risk of ischaemic heart disease: The Speedwell Study
|
|
|
1998 |
|
S1 |
p. 9- 1 p. |
artikel |
87 |
178 Fibrin D-dimer levels in a pregnant woman homozygous for FV Leiden
|
|
|
1998 |
|
S1 |
p. 64- 1 p. |
artikel |
88 |
Fibrinogen and atherosclerosis: a study in transgenic mice
|
Koopman, J. |
|
1997 |
|
S1 |
p. 19-21 3 p. |
artikel |
89 |
204 Fibrinogen-heparin interaction. Biochemical and functional importance
|
|
|
1998 |
|
S1 |
p. 75- 1 p. |
artikel |
90 |
Fibrinogen mediates vasoactive effects in saphenous vein by an ICAM-1 dependent pathway
|
Hicks, R.C.J. |
|
1997 |
|
S1 |
p. 27-29 3 p. |
artikel |
91 |
220 Fibrinolysis in female with malignant diseases: Ca mammae et Ca cervicis uteri
|
|
|
1998 |
|
S1 |
p. 81- 1 p. |
artikel |
92 |
93 Fibrinolytic activity, functional fibrinogen and triglycerides in insulin dependent diabetes mellitus
|
|
|
1998 |
|
S1 |
p. 33- 1 p. |
artikel |
93 |
159 Fibrinolytic activity in patients with myocardial infarction
|
|
|
1998 |
|
S1 |
p. 57- 1 p. |
artikel |
94 |
162 Fibrinolytic activity in preterm and full-term neonates
|
|
|
1998 |
|
S1 |
p. 58- 1 p. |
artikel |
95 |
203 Fibrinolytic complex of heparin with glutamic acid
|
|
|
1998 |
|
S1 |
p. 74- 1 p. |
artikel |
96 |
216 Fibrinolytic disturbances in chronic myeloid leukaemia
|
|
|
1998 |
|
S1 |
p. 80- 1 p. |
artikel |
97 |
226 Fibrinolytic parameters are not risk factors for developing restenosis after recanalisation procedures in peripheral arteries
|
|
|
1998 |
|
S1 |
p. 83- 1 p. |
artikel |
98 |
133 Fibrinolytic properties of activated factor XII
|
|
|
1998 |
|
S1 |
p. 47- 1 p. |
artikel |
99 |
158 Fibrinolytic response to venous occlusion compared to exercise stress in young patients with coronary artery disease and healthy controls
|
|
|
1998 |
|
S1 |
p. 56- 1 p. |
artikel |
100 |
23 Fibrinolytic variables as predictors of restenosis after PTCA
|
|
|
1998 |
|
S1 |
p. 10- 1 p. |
artikel |
101 |
79 Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro
|
|
|
1998 |
|
S1 |
p. 29- 1 p. |
artikel |
102 |
190 Focal increase in tPA activity and extracellular proteolysis were observed prior to neuronal cell death in the hippocampus after kainic acid injection
|
|
|
1998 |
|
S1 |
p. 69- 1 p. |
artikel |
103 |
Foreword
|
Koenig, W |
|
1997 |
|
S1 |
p. 1- 1 p. |
artikel |
104 |
223 Fraxiparine administration in pregnants with cardiac pathology and thrombophilia
|
|
|
1998 |
|
S1 |
p. 82- 1 p. |
artikel |
105 |
222 Fraxiparine in treatment of chronic DIC-syndrome in patients with EPH-gestosis
|
|
|
1998 |
|
S1 |
p. 82- 1 p. |
artikel |
106 |
102 Functional consequences of the up-modulation of plasminogen receptors on leukocytes
|
|
|
1998 |
|
S1 |
p. 36- 1 p. |
artikel |
107 |
135 Functional role of soluble cell adhesion molecules (sCAM) in atherosclerosis
|
|
|
1998 |
|
S1 |
p. 48- 1 p. |
artikel |
108 |
244 -455 G/A fibrinogen promoter polymorphism and Cytomegalovirus infection modulate fibrinogen levels but not the risk of premature coronary heart disease
|
|
|
1998 |
|
S1 |
p. 90- 1 p. |
artikel |
109 |
Gene-environment interaction in the determination of plasma levels of fibrinogen
|
Humphries, S.E. |
|
1997 |
|
S1 |
p. 3-7 5 p. |
artikel |
110 |
250 Gene expression of fibrinolytic factors in regenerating mice liver
|
|
|
1998 |
|
S1 |
p. 93- 1 p. |
artikel |
111 |
32 Genetherapy with adenovirus expressing ATF-BPTI hybrid protein inhibits proteolysis by rheumatoid synovial fibroblasts
|
|
|
1998 |
|
S1 |
p. 13- 1 p. |
artikel |
112 |
105 Genetic determinant on PAI-1 levels: A study in twins
|
|
|
1998 |
|
S1 |
p. 37- 1 p. |
artikel |
113 |
Haemostatic system and arterial disease: future perspectives
|
Meade, T.W. |
|
1997 |
|
S1 |
p. 167-171 5 p. |
artikel |
114 |
177 Hemocoagulative alterations in patients with acute myocardial infarction and in relatives: comparison with healthy individuals
|
|
|
1998 |
|
S1 |
p. 63- 1 p. |
artikel |
115 |
54 Hemostaseologic and molecular genetic studies in four patients with severe type I plasminogen (Plg) deficiency and ligneous conjunctivitis
|
|
|
1998 |
|
S1 |
p. 20- 1 p. |
artikel |
116 |
258 Hepatocyte growth factor (HGF) stimulates plasminogen activator inhibitor-1 (PAI-1) and vascular endothelial growth factor (VEGF) in human keratinocytes and KDR in human endothelial cells in vitro
|
|
|
1998 |
|
S1 |
p. 95- 1 p. |
artikel |
117 |
147 Heterogeneous distribution of the subclass IgG anti-streptokinase antibodies
|
|
|
1998 |
|
S1 |
p. 53- 1 p. |
artikel |
118 |
24 High Lp(a) levels: Possible risk factor for restenosis after PTCA
|
|
|
1998 |
|
S1 |
p. 10- 1 p. |
artikel |
119 |
Homocysteine, atherogenesis and thrombosis
|
Harpel, P.C. |
|
1997 |
|
S1 |
p. 77-80 4 p. |
artikel |
120 |
How does hyperfibrinogenemia lead to thrombosis?
|
McDonagh, J. |
|
1997 |
|
S1 |
p. 13-17 5 p. |
artikel |
121 |
How to detect activated coagulation
|
Bauer, K.A. |
|
1997 |
|
S1 |
p. 23-26 4 p. |
artikel |
122 |
255 Human mast cells express functional uPAR/CD87
|
|
|
1998 |
|
S1 |
p. 94- 1 p. |
artikel |
123 |
1 Human plasminogen kringle 2: Ligand binding properties and NMR solution structure
|
|
|
1998 |
|
S1 |
p. 3- 1 p. |
artikel |
124 |
Hyperfibrinogenemia and cardiovascular risk: possible strategies for intervention
|
Koenig, W. |
|
1997 |
|
S1 |
p. 41-46 6 p. |
artikel |
125 |
Hyperinsulinemia increases plasma activity of PAI-1 in vivo independently of an acute phase reaction
|
Nordt, T.K. |
|
1997 |
|
S1 |
p. 51-54 4 p. |
artikel |
126 |
229 Hypofibrinolysis in patients with thrombosis or recurrent miscarriages
|
|
|
1998 |
|
S1 |
p. 84- 1 p. |
artikel |
127 |
237 Hypoplasminogenemia and factor V Leiden defect in a family with thrombotic tendency
|
|
|
1998 |
|
S1 |
p. 88- 1 p. |
artikel |
128 |
111 Identification and localization of protein C inhibitor (PCI) in resting platelets
|
|
|
1998 |
|
S1 |
p. 39- 1 p. |
artikel |
129 |
199 Identification of two novel splice site mutations responsible for type I antithrombin deficiency
|
|
|
1998 |
|
S1 |
p. 73- 1 p. |
artikel |
130 |
III TAFI (procarboxypeptidase b) compared to the other inhibitors of the fibrinolytic system
|
|
|
1998 |
|
S1 |
p. 1- 1 p. |
artikel |
131 |
II Tissue plasminogen activator and plasminogen in the brain
|
|
|
1998 |
|
S1 |
p. 1- 1 p. |
artikel |
132 |
110 Immunofluorescence analysis of t-PA in human endothelial cells
|
|
|
1998 |
|
S1 |
p. 39- 1 p. |
artikel |
133 |
117 Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women
|
|
|
1998 |
|
S1 |
p. 41- 1 p. |
artikel |
134 |
57 Impaired fibrinolysis associated to FV R506Q mutation in patients with a history of atherothrombotic stroke
|
|
|
1998 |
|
S1 |
p. 21- 1 p. |
artikel |
135 |
55 Impaired release of tissue-type plasminogen activator (t-PA) from vascular endothelium in essential hypertension
|
|
|
1998 |
|
S1 |
p. 21- 1 p. |
artikel |
136 |
156 Impairment of fibrinolysis after PTCA and restenosis
|
|
|
1998 |
|
S1 |
p. 56- 1 p. |
artikel |
137 |
242 Incidence of factor V Leiden and the prothrombin variant 20210 G→A in the Navarrese population: Preliminary studies in a group of Navarrese patients with venous thrombosis
|
|
|
1998 |
|
S1 |
p. 89- 1 p. |
artikel |
138 |
186 Increased fibrinolytic gene expression in pulmonary artery
|
|
|
1998 |
|
S1 |
p. 68- 1 p. |
artikel |
139 |
174 Increased PAI-1 levels and venous thromboembolism
|
|
|
1998 |
|
S1 |
p. 62- 1 p. |
artikel |
140 |
201 Increased tissue factor and tissue factor pathway inhibitor levels in the lungs of idiopathic pulmonary fibrosis patients associated with elevated procoagulant activity
|
|
|
1998 |
|
S1 |
p. 74- 1 p. |
artikel |
141 |
64 Induction of type-1 plasminogen activator inhibitor (PAI-1) gene expression by thiazolidinediones during adipocyte differentiation
|
|
|
1998 |
|
S1 |
p. 24- 1 p. |
artikel |
142 |
101 Induction of tyrosine phosphorylation by the interaction of tissue-type plasminogen activator (t-PA) and its receptor (t-PAR) in human endothelial cells
|
|
|
1998 |
|
S1 |
p. 36- 1 p. |
artikel |
143 |
192 Induction of urokinase-type plasminogen activator by oxidative stress in RC-K8 Human pre-B lymphoma cells
|
|
|
1998 |
|
S1 |
p. 70- 1 p. |
artikel |
144 |
Infection, hemostatic factors and cardiovascular disease
|
Khaw, K.T. |
|
1997 |
|
S1 |
p. 149-153 5 p. |
artikel |
145 |
Inflammation in atherosclerotic plaques: a clinically crucial event
|
van der Wal, A.C. |
|
1997 |
|
S1 |
p. 125-128 4 p. |
artikel |
146 |
Inflammation: the protein C pathway
|
Esmon, C.T. |
|
1997 |
|
S1 |
p. 143-148 6 p. |
artikel |
147 |
Inflammatory markers as predictors in unstable angina
|
de Maat, M.P.M. |
|
1997 |
|
S1 |
p. 135-136 2 p. |
artikel |
148 |
185 Influence of vasopressin analogues on plasminogen activator release
|
|
|
1998 |
|
S1 |
p. 67- 1 p. |
artikel |
149 |
11 Infusion of anti-PAI-1 monoclonal antibodies to rabbits given endotoxin to induce DIC
|
|
|
1998 |
|
S1 |
p. 6- 1 p. |
artikel |
150 |
173 Inherited thrombophillia and pregnancy — high risk combination for thrombosis
|
|
|
1998 |
|
S1 |
p. 62- 1 p. |
artikel |
151 |
215 INR results from 4 prothrombin time (PT) reagents, using different reference times, compared
|
|
|
1998 |
|
S1 |
p. 79- 1 p. |
artikel |
152 |
121 Interaction of plasminogen and tPA with immobilised enolase studied by surface plasmon resonance (SPR)
|
|
|
1998 |
|
S1 |
p. 43- 1 p. |
artikel |
153 |
89 Interactions between stromelysin-1 (MMP-3) and the plasminogen/urokinase-type plasminogen activator (u-PA) system
|
|
|
1998 |
|
S1 |
p. 32- 1 p. |
artikel |
154 |
5 Interface scanning and 3D model of the staphylokinase:plasmin activator complex
|
|
|
1998 |
|
S1 |
p. 4- 1 p. |
artikel |
155 |
254 Intracellular signaling in retinoic-induced NB4 cell differentiation and fibrinolysis regulation
|
|
|
1998 |
|
S1 |
p. 94- 1 p. |
artikel |
156 |
48 In vivo evidence for a role of coagulation factor XI as an anti-fibrinolytic factor in a rabbit jugular vein thrombosis model
|
|
|
1998 |
|
S1 |
p. 18- 1 p. |
artikel |
157 |
231 Is tranexamic acid a therapeutic possibility for recurrent bleeding from colonic angiodysplastic lesions in hemodialysis patients ?
|
|
|
1998 |
|
S1 |
p. 85- 1 p. |
artikel |
158 |
I The current role of thrombolytic therapy in clinical practice
|
|
|
1998 |
|
S1 |
p. 1- 1 p. |
artikel |
159 |
IV Metalloproteases in remodeling of the extracellular matrix
|
|
|
1998 |
|
S1 |
p. 2- 1 p. |
artikel |
160 |
228 Lack of correlation between fibrinolytic capacity and vascular recanalization in deep vein thrombosis
|
|
|
1998 |
|
S1 |
p. 84- 1 p. |
artikel |
161 |
163 Laparascopic cholecistectomy: Thrombosis prophylaxis with low molecular weight heparin (LMWH)
|
|
|
1998 |
|
S1 |
p. 58- 1 p. |
artikel |
162 |
94 Leukocyte and plasma PAs and PAIs in major sepsis
|
|
|
1998 |
|
S1 |
p. 34- 1 p. |
artikel |
163 |
30 Levels of carboxypeptidase B (thrombin-activatable fibrinolysis inhibitor: TAFI) following thrombolysis with streptokinase
|
|
|
1998 |
|
S1 |
p. 12- 1 p. |
artikel |
164 |
153 Lifestyle and other risk factors and fibrinolytic risk factors for ischaemic heart disease: The Caerphilly Study
|
|
|
1998 |
|
S1 |
p. 55- 1 p. |
artikel |
165 |
116 Lipoprotein(a) [Lp(a)]levels and isoforms and fibrinolytic activity in postmenopause. Influence of hormone replacement therapy (HRT)
|
|
|
1998 |
|
S1 |
p. 41- 1 p. |
artikel |
166 |
260 Lipoprotein(a) phenotypes display differences in the expression of PAI-1 mRNA in human brain microvessel endothelial cells
|
|
|
1998 |
|
S1 |
p. 96- 1 p. |
artikel |
167 |
Lipoproteins and inflammation in atherosclerosis
|
Nilsson, J. |
|
1997 |
|
S1 |
p. 129-132 4 p. |
artikel |
168 |
84 Local fibrinolytic treatment in 163 patients with acute ischemia of lower limb
|
|
|
1998 |
|
S1 |
p. 30- 1 p. |
artikel |
169 |
109 Local insulin infusion stimulates the expression of plasminogen activator inhibitor-1 and tissue plasminogen activator in normal subjects
|
|
|
1998 |
|
S1 |
p. 39- 1 p. |
artikel |
170 |
125 Localization of the human antistreptokinase IgG epitopes on streptokinase
|
|
|
1998 |
|
S1 |
p. 44- 1 p. |
artikel |
171 |
13 Loop insertion propels acylation and enhances recognition of tPA by PAI-1
|
|
|
1998 |
|
S1 |
p. 7- 1 p. |
artikel |
172 |
22 Low grade inflammation, fibrinolysis, and evolution of future coronary heart disease in initially healthy men and women
|
|
|
1998 |
|
S1 |
p. 10- 1 p. |
artikel |
173 |
Lp(a) lipoprotein and risk of atherosclerotic/thrombotic disease
|
Berg, K. |
|
1997 |
|
S1 |
p. 71-75 5 p. |
artikel |
174 |
98 Mapping contact areas of uPA/inhibitor complexes and receptor-associated-protein with endocytosis receptors by the use of monoclonal antibodies and genetically and proteolytically modified ligands and receptors
|
|
|
1998 |
|
S1 |
p. 35- 1 p. |
artikel |
175 |
170 Markers of thrombophilia in symptomatic and asymptomatic carriers of homozygous factor V Leiden
|
|
|
1998 |
|
S1 |
p. 61- 1 p. |
artikel |
176 |
127 Mathematic model of fibrin clot lysis by plasmin
|
|
|
1998 |
|
S1 |
p. 45- 1 p. |
artikel |
177 |
87 Matrix metalloproteinase expression after vascular injury in mice
|
|
|
1998 |
|
S1 |
p. 31- 1 p. |
artikel |
178 |
Mechanisms for thrombolysis-induced increases in procoagulant and proinflammatory activity
|
Schaiff, W.T. |
|
1997 |
|
S1 |
p. 115-118 4 p. |
artikel |
179 |
7 Melagatran, a novel thrombin inhibitor, reduces renal and haemodynamic effects of endotoxin in the pig
|
|
|
1998 |
|
S1 |
p. 5- 1 p. |
artikel |
180 |
205 Menaquinone types of vitamin K (MK-4 and MK-7) increased after ingestion of phylloquinone foods
|
|
|
1998 |
|
S1 |
p. 75- 1 p. |
artikel |
181 |
58 Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism
|
|
|
1998 |
|
S1 |
p. 22- 1 p. |
artikel |
182 |
85 MMP-9 and MMP-2 activities in stomach and breast tumours, as measured by a novel MMP activity assay using modified urokinase as a substrate
|
|
|
1998 |
|
S1 |
p. 31- 1 p. |
artikel |
183 |
Molecular markers of hemostasis and fibrinolysis and inhibitor levels in unstable angina pectoris
|
Hoffmeister, H.M. |
|
1997 |
|
S1 |
p. 61-65 5 p. |
artikel |
184 |
27 Molecular mass dependence and the effect of TAFIa on the t-PA and DSPA cofactor activities of soluble fibrin degradation products
|
|
|
1998 |
|
S1 |
p. 11- 1 p. |
artikel |
185 |
141 Monoclonal antibodies specific for D-dimer
|
|
|
1998 |
|
S1 |
p. 50- 1 p. |
artikel |
186 |
47 Monocyte chemotactic protein 1 (MCP-1) accelerates thrombus resolution
|
|
|
1998 |
|
S1 |
p. 18- 1 p. |
artikel |
187 |
67 Multicentric evaluation of a new test for the quantification of D-dimer: STA-liatest D-Di
|
|
|
1998 |
|
S1 |
p. 25- 1 p. |
artikel |
188 |
262 Multiple transcripts for apolipoprotein(a)-related gene II generated by alternative splicing in tissue- and cell type-specific manners
|
|
|
1998 |
|
S1 |
p. 97- 1 p. |
artikel |
189 |
214 Near patient fibrinogen assay for monitoring ancrod treatment of ischemic stroke
|
|
|
1998 |
|
S1 |
p. 78- 1 p. |
artikel |
190 |
New antithrombotic agents: an overview
|
Windstetter, U. |
|
1997 |
|
S1 |
p. 85-96 12 p. |
artikel |
191 |
New developments in thrombolytic therapy
|
Bode, C. |
|
1997 |
|
S1 |
p. 109-114 6 p. |
artikel |
192 |
167 Nitric oxide and fibrinolytic system in sepsis
|
|
|
1998 |
|
S1 |
p. 59- 1 p. |
artikel |
193 |
154 No effect of wheat grain supplementation in diet on blood fibrinolysis in subjects with metabolic cardiovascular syndrome
|
|
|
1998 |
|
S1 |
p. 55- 1 p. |
artikel |
194 |
78 On the mechanism of fibrin-induced down-regulation of PAI-2 production by monocytes
|
|
|
1998 |
|
S1 |
p. 28- 1 p. |
artikel |
195 |
146 Open heart surgery and the platelet function measured with PFA-100®
|
|
|
1998 |
|
S1 |
p. 52- 1 p. |
artikel |
196 |
91 PAI-1 antigen production by human adipose tissue is correlated with that of TNFα
|
|
|
1998 |
|
S1 |
p. 33- 1 p. |
artikel |
197 |
246 PAI-1 4G/5G polymorphism and deep venous thrombosis in factor V Leiden patients
|
|
|
1998 |
|
S1 |
p. 91- 1 p. |
artikel |
198 |
103 PAI-1 promoter polymorphism and elevated PAI-1 circulating levels in postmenopausal women with coronary artery disease
|
|
|
1998 |
|
S1 |
p. 37- 1 p. |
artikel |
199 |
33 PAI-1 regulates adhesion of fibrosarcoma cells by promoting internalisation of uPAR/uPA/PAI-1 complexes
|
|
|
1998 |
|
S1 |
p. 13- 1 p. |
artikel |
200 |
90 Pathological consequences associated with altered expression of components of the plasminogen system in bleomycin induced pulmonary fibrosis
|
|
|
1998 |
|
S1 |
p. 32- 1 p. |
artikel |
201 |
Pathophysiology of acute ischemic syndromes: recent progress
|
Kristensen, S.D. |
|
1997 |
|
S1 |
p. 105-108 4 p. |
artikel |
202 |
81 PEGylation of fibrolase overcomes inhibition by α2-macroglobulin
|
|
|
1998 |
|
S1 |
p. 29- 1 p. |
artikel |
203 |
96 Peritoneal concentration of TGF-β is associated with PAI-1 and increased peritoneal adhesion formation
|
|
|
1998 |
|
S1 |
p. 34- 1 p. |
artikel |
204 |
171 Phospholipid antibodies and their inhibitory effect on factor XII
|
|
|
1998 |
|
S1 |
p. 61- 1 p. |
artikel |
205 |
63 PKC-β and MAPK are required for the synthesis of PAI-1 during the phorbol ester-mediated adhesion of the human cell line HL-60
|
|
|
1998 |
|
S1 |
p. 23- 1 p. |
artikel |
206 |
Plasma fibrinogen and wall thickness in carotid and femoral arteries: findings from the KIHD study
|
Salonen, J.T. |
|
1997 |
|
S1 |
p. 35-40 6 p. |
artikel |
207 |
160 Plasma PAI-1 and its release from platelets is related to the reduced platelet reactivity in patients with ischaemic heart disease
|
|
|
1998 |
|
S1 |
p. 57- 1 p. |
artikel |
208 |
122 Plasmin-catalyzed hydrolysis of substrates being the titrants of the enzyme active site
|
|
|
1998 |
|
S1 |
p. 43- 1 p. |
artikel |
209 |
41 Plasminogen activator inhibitor 2 (PAI-2) is cross-linked to fibrin and efficiently inhibits u-PA-mediated fibrinolysis
|
|
|
1998 |
|
S1 |
p. 16- 1 p. |
artikel |
210 |
106 Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism 4G/5G and plasma PAI-1 levels in subjects with ischaemic heart disease
|
|
|
1998 |
|
S1 |
p. 38- 1 p. |
artikel |
211 |
107 Plasminogen activator inhibitor 1 promoter: Analysis of responsive elements with respect to promoter polymorphism
|
|
|
1998 |
|
S1 |
p. 38- 1 p. |
artikel |
212 |
248 Plasminogen activators and inhibitors in blood of fetus with good obstetric outcome compared to normal neonates and hydrops fetalis
|
|
|
1998 |
|
S1 |
p. 92- 1 p. |
artikel |
213 |
151 Plasminogen activators (t-PA, u-PA) and plasminogen activator inhibitor type 1 (PAI-1) in hemodialysed patients with chronic renal failure
|
|
|
1998 |
|
S1 |
p. 54- 1 p. |
artikel |
214 |
113 Plasminogen binding and activation during cell death
|
|
|
1998 |
|
S1 |
p. 40- 1 p. |
artikel |
215 |
134 Platelet adhesion and plasmin generation on immobilized and FXIII crosslinked fibrin(ogen)
|
|
|
1998 |
|
S1 |
p. 48- 1 p. |
artikel |
216 |
144 Platelet Na+/H+ exchange and plasminogen activator inhibitor in patients with primary hypertension
|
|
|
1998 |
|
S1 |
p. 52- 1 p. |
artikel |
217 |
155 Possible relation of intraplatelet PAI-1 to 4G/5G polymorphism in patients undergoing cardiopulmonary bypass surgery
|
|
|
1998 |
|
S1 |
p. 55- 1 p. |
artikel |
218 |
175 Prekallikrein levels in populations of blood donors and patients receiving oral anticoagulants
|
|
|
1998 |
|
S1 |
p. 63- 1 p. |
artikel |
219 |
34 Preliminary study of uPAR and plasminogen activators and inhibitors in tissues from benign and ovarian cancer
|
|
|
1998 |
|
S1 |
p. 14- 1 p. |
artikel |
220 |
238 Prenatal diagnosis in a family with severe type I plasminogen (PLG) deficiency and ligneous conjunctivitis
|
|
|
1998 |
|
S1 |
p. 88- 1 p. |
artikel |
221 |
128 Procarboxypeptidase U in plasma from different animal species
|
|
|
1998 |
|
S1 |
p. 45- 1 p. |
artikel |
222 |
200 Prognostic value of ATIII in MODS
|
|
|
1998 |
|
S1 |
p. 73- 1 p. |
artikel |
223 |
236 Protective effect of a prostaglandin I2 analogue on graft liver subjected to in situ warm ischemia in porcine liver transplantation: Immunohistochemical analysis of thrombomodulin
|
|
|
1998 |
|
S1 |
p. 87- 1 p. |
artikel |
224 |
136 Proteolysis of NCAM and PSA-NCAM by the tissue plasminogen activator-plasmin system
|
|
|
1998 |
|
S1 |
p. 48- 1 p. |
artikel |
225 |
207 Purification and molecular cloning of salmobin, a thrombin-like enzyme from korean salmosa snake (Agkistrodon halys)
|
|
|
1998 |
|
S1 |
p. 76- 1 p. |
artikel |
226 |
61 Purification of a DNA binding protein that interact with the PAI-1 promoter
|
|
|
1998 |
|
S1 |
p. 23- 1 p. |
artikel |
227 |
35 Rapid auto-catalytic processing of Glu-plasminogen occurs on malignant breast cancer cell-surfaces
|
|
|
1998 |
|
S1 |
p. 14- 1 p. |
artikel |
228 |
232 Rapid clot lysis induced by local administration of tPA + Lys-plasminogen in the rabbit jugular vein thrombosis model
|
|
|
1998 |
|
S1 |
p. 86- 1 p. |
artikel |
229 |
245 Rapid genetic diagnosis for abnormal plasminogen by multiple amplification refractory mutation system (MARMS) and automated capillary electrophoresis
|
|
|
1998 |
|
S1 |
p. 90- 1 p. |
artikel |
230 |
Recent advances in hemostatic risk factors and cardiovascular diseases
|
Wu, K.K. |
|
1997 |
|
S1 |
p. 31-34 4 p. |
artikel |
231 |
189 Redistribution of vascular APOER2 expression after vascular injury
|
|
|
1998 |
|
S1 |
p. 69- 1 p. |
artikel |
232 |
60 Reduced levels of tPA antigen and soluble thrombomodulin in patients with coronary heart disease after supplementation with omega-3 fatty acids
|
|
|
1998 |
|
S1 |
p. 22- 1 p. |
artikel |
233 |
86 Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system
|
|
|
1998 |
|
S1 |
p. 31- 1 p. |
artikel |
234 |
188 Regulation of rat and human plasminogen gene expression during acute phase
|
|
|
1998 |
|
S1 |
p. 68- 1 p. |
artikel |
235 |
209 Relationship between blood lipids and euglobulin clot lysis time evaluated by a new method
|
|
|
1998 |
|
S1 |
p. 77- 1 p. |
artikel |
236 |
120 Relationship between soluble fibrin and X-oligomer following elective PTCA
|
|
|
1998 |
|
S1 |
p. 42- 1 p. |
artikel |
237 |
43 Role of plasminogen activator inhibitor-1 in ischemia/reperfusion injury of rat liver
|
|
|
1998 |
|
S1 |
p. 17- 1 p. |
artikel |
238 |
10 Selective inhibition of factor Xa by the synthetic inhibitor DX-9065a reduces thrombotic reocclusion after lysis of jugular vein thrombosis in rabbits
|
|
|
1998 |
|
S1 |
p. 6- 1 p. |
artikel |
239 |
49 Separate and joint effect of DDAVP infusion and exercise on blood fibrinolytic activity — evidence of two different mechanisms of t-PA increase
|
|
|
1998 |
|
S1 |
p. 19- 1 p. |
artikel |
240 |
145 Shear-, coagulation- and fibrinolysis- induced cytokines expression in atherosclerosis
|
|
|
1998 |
|
S1 |
p. 52- 1 p. |
artikel |
241 |
187 Shear-stress-induced t-PA gene expression in vascular endothelium in intact human conduit vessels
|
|
|
1998 |
|
S1 |
p. 68- 1 p. |
artikel |
242 |
261 Smooth muscle cell apoptosis is one of the key mechanisms underlying aortic dilatation in congenital aortic valve malformations
|
|
|
1998 |
|
S1 |
p. 96- 1 p. |
artikel |
243 |
119 Soluble fibrin and X-oligomer levels following streptokinase therapy of acute myocardial infarction
|
|
|
1998 |
|
S1 |
p. 42- 1 p. |
artikel |
244 |
256 Some aspects of regulation of plasminogen activator and u-PAR antigens expression in U937, THP-1 and K562 cell lines
|
|
|
1998 |
|
S1 |
p. 95- 1 p. |
artikel |
245 |
Some interactions between the haemostatic system and lipids
|
Miller, G.J. |
|
1997 |
|
S1 |
p. 67-69 3 p. |
artikel |
246 |
70 Specific ELISAs for quantitation of rat PAI-1 antigen and activity in biological samples
|
|
|
1998 |
|
S1 |
p. 26- 1 p. |
artikel |
247 |
132 Specific inhibition of Lp(a) binding to fibrin preserving plasminogen function
|
|
|
1998 |
|
S1 |
p. 47- 1 p. |
artikel |
248 |
71 Specific quantitation of thrombin inhibitors using ecarin clotting time: Application in point-of-care testing
|
|
|
1998 |
|
S1 |
p. 26- 1 p. |
artikel |
249 |
124 Standardisation of various urokinases. Effect of glycosylation on activity
|
|
|
1998 |
|
S1 |
p. 44- 1 p. |
artikel |
250 |
95 Steroids withdrawal normalize the reduced fibrinolytic capacity in renal transplant patients
|
|
|
1998 |
|
S1 |
p. 34- 1 p. |
artikel |
251 |
15 β-strand 5A of PAI-1 mediates transfer of conformational changes from the flexible joints region and α-helix F to the reactive centre loop
|
|
|
1998 |
|
S1 |
p. 7- 1 p. |
artikel |
252 |
225 Stress and fibrinolysis: blood parameters in relation to body parameters
|
|
|
1998 |
|
S1 |
p. 83- 1 p. |
artikel |
253 |
38 Structural insights into the PAI-1-uPA complex
|
|
|
1998 |
|
S1 |
p. 15- 1 p. |
artikel |
254 |
39 Structure function relationships of plasminogen activator inhibitor type-2 (PAI-2)
|
|
|
1998 |
|
S1 |
p. 15- 1 p. |
artikel |
255 |
241 Studies on fibrinolysis in homozyous type I plasminogen deficiency
|
|
|
1998 |
|
S1 |
p. 89- 1 p. |
artikel |
256 |
Subject index
|
|
|
1997 |
|
S1 |
p. 173-176 4 p. |
artikel |
257 |
233 Supression of PAI-1 activity levels in rat plasma by monoclonal antibodies
|
|
|
1998 |
|
S1 |
p. 86- 1 p. |
artikel |
258 |
150 Systemic inflammatory reaction may explain the activation of coagulation and fibrinolysis in patients with chronic renal failure (CRF)
|
|
|
1998 |
|
S1 |
p. 54- 1 p. |
artikel |
259 |
208 Targeting of the mouse protein C inhibitor gene
|
|
|
1998 |
|
S1 |
p. 76- 1 p. |
artikel |
260 |
46 Textilinins from Pseudonaja textilis textilis. Characterisation of two novel plasmin inhibitors which inhibit bleeding in an animal model
|
|
|
1998 |
|
S1 |
p. 18- 1 p. |
artikel |
261 |
65 TGF-β and HGF synergistically induce PAI-1 in rat FTO-2B hepatoma cells: Interaction of transcriptional and post-transcriptional mechanisms
|
|
|
1998 |
|
S1 |
p. 24- 1 p. |
artikel |
262 |
234 The action of Lonomia achelous caterpillars venom on some blood coagulation factors of the rabbit
|
|
|
1998 |
|
S1 |
p. 86- 1 p. |
artikel |
263 |
181 The antiplatelet and fibrinolytic activity of the simplest prolin-containing peptides
|
|
|
1998 |
|
S1 |
p. 65- 1 p. |
artikel |
264 |
166 The association of factor V Leiden and thromboembolism in patient with prosthetic heart valves
|
|
|
1998 |
|
S1 |
p. 59- 1 p. |
artikel |
265 |
114 The effect of argatroban on staphylokinase activity in the presence of endothelial cell injured by thrombin
|
|
|
1998 |
|
S1 |
p. 40- 1 p. |
artikel |
266 |
99 The effect of cell-density on the production of plasminogen activators and PAI-1 by human vascular smooth muscle cells
|
|
|
1998 |
|
S1 |
p. 35- 1 p. |
artikel |
267 |
251 The endometrial signal for endothelial cell migration is related to the u-PA system, and is modulated by ovarian steroids
|
|
|
1998 |
|
S1 |
p. 93- 1 p. |
artikel |
268 |
239 The 4G/5G genetic polymorphism of the plasminogen activator inhibitor-1 (PAI-1) promoter is not associated with the plasma PAI-1 levels in newborns
|
|
|
1998 |
|
S1 |
p. 88- 1 p. |
artikel |
269 |
108 The 4G/5G polymorphism of PAI-1 promoter gene as a risk factor for myocardial infarction: A meta-analysis approach
|
|
|
1998 |
|
S1 |
p. 38- 1 p. |
artikel |
270 |
51 The ginseng preparation Xuesaitong up-regulates plasminogen activator expression in human endothelial cells
|
|
|
1998 |
|
S1 |
p. 19- 1 p. |
artikel |
271 |
210 The global fibrinolytic capacity (GFC), a promising method for hypofibrinolytic state detection in thrombotic diseases
|
|
|
1998 |
|
S1 |
p. 77- 1 p. |
artikel |
272 |
247 The hemostatic-fibrinolytic profiles of human follicular fluid in the preovulatory phase
|
|
|
1998 |
|
S1 |
p. 92- 1 p. |
artikel |
273 |
161 The influence of plasmapheresis on dynamics of DIC-syndrome and hospital mortality in patients during acute period of myocardial infarction
|
|
|
1998 |
|
S1 |
p. 57- 1 p. |
artikel |
274 |
249 The influences of sex steroid hormones on production of fibrinolysis and anti-fibrinolysis factors in cultured human trophoblastic and endometrial cells
|
|
|
1998 |
|
S1 |
p. 92- 1 p. |
artikel |
275 |
152 The investigations in vivo and in vitro of the atherosclerosis, myocardial infarction and physical-chemical characteristics of human blood plasma
|
|
|
1998 |
|
S1 |
p. 54- 1 p. |
artikel |
276 |
195 The kinetics of tPA inhibition by C1-inhibitor in vivo and in vitro
|
|
|
1998 |
|
S1 |
p. 71- 1 p. |
artikel |
277 |
194 The limited cleavage and inactivation of PAI-1 by reptilase at high doses but not by defibrase
|
|
|
1998 |
|
S1 |
p. 71- 1 p. |
artikel |
278 |
16 The role of amino acid residues in the S2 and S3 strands in the B β-sheet for the PAI-1 stability
|
|
|
1998 |
|
S1 |
p. 8- 1 p. |
artikel |
279 |
The role of platelets in the early and late vascular responses initiated by mechanical vascular injury
|
Harker, L.A. |
|
1997 |
|
S1 |
p. 97-103 7 p. |
artikel |
280 |
14 The variable region-1 of t-PA confers specificity for PAI-1 by facilitating catalysis, not affinity
|
|
|
1998 |
|
S1 |
p. 7- 1 p. |
artikel |
281 |
29 Thrombin-activatable fibrinolysis inhibitor slows clot lysis in rats, rabbits and dogs
|
|
|
1998 |
|
S1 |
p. 12- 1 p. |
artikel |
282 |
149 Thrombin generation, endothelial cell function and fibrinolytic potential in homozygous sickle cell disease and beta-thalassemia
|
|
|
1998 |
|
S1 |
p. 53- 1 p. |
artikel |
283 |
82 Thrombolytic activity of u-PA/t-PA chimera (K2tu-PA) evaluated with arterial type (Chandler) thrombi
|
|
|
1998 |
|
S1 |
p. 30- 1 p. |
artikel |
284 |
83 Thrombolytic properties of poorly immunogenic variants of recombinant staphylokinase
|
|
|
1998 |
|
S1 |
p. 30- 1 p. |
artikel |
285 |
139 TintElize tPA·PAI-1, a new method for the measurement of tPA·PAI-1 complexes
|
|
|
1998 |
|
S1 |
p. 49- 1 p. |
artikel |
286 |
230 Tissue plasminogen activator increased only in the hippocampus following the transient forebrain ischemia, which may be related to neuronal cell death
|
|
|
1998 |
|
S1 |
p. 85- 1 p. |
artikel |
287 |
88 Tissue remodelling in the ovary by plasminogen activators and matrix metalloproteinases: Regulation and functional role revealed by gene deficient mice
|
|
|
1998 |
|
S1 |
p. 32- 1 p. |
artikel |
288 |
56 tPA-PAI-1 complex as a risk factor for the development of a first stroke
|
|
|
1998 |
|
S1 |
p. 21- 1 p. |
artikel |
289 |
45 Transient expression of tissue plasminogen activator in the developing arterial system
|
|
|
1998 |
|
S1 |
p. 17- 1 p. |
artikel |
290 |
218 Triglyceride as predictor of both t-PA and PAI-1: Studies in non obese hypertriglyceridemic patients
|
|
|
1998 |
|
S1 |
p. 80- 1 p. |
artikel |
291 |
75 Ultrastructural location of the carboxy-terminal region of γ chains in fibrin(ogen) molecules labeled with a gold cluster cadaverine compound at crosslinking sites
|
|
|
1998 |
|
S1 |
p. 27- 1 p. |
artikel |
292 |
62 Unsaturated fatty acids increase PAI-1 expression in endothelial cells
|
|
|
1998 |
|
S1 |
p. 23- 1 p. |
artikel |
293 |
Urinary 8-EPI PGF2α: an index of oxidant stress in vivo
|
Reilly, M.P. |
|
1997 |
|
S1 |
p. 81-84 4 p. |
artikel |
294 |
253 Urokinase plasminogen activator (u-PA) and its inhibitors (PAI-1, PAI-2) in tissue extracts of planoepithelial lung cancer
|
|
|
1998 |
|
S1 |
p. 94- 1 p. |
artikel |
295 |
191 Urokinase type plasminogen activator (u-PA) and its inhibitors (PAI-1, PAI-2) in extracts of planoepithelial larynx cancer
|
|
|
1998 |
|
S1 |
p. 69- 1 p. |
artikel |
296 |
21 Urokinase-type plasminogen activator (u-PA) and the risk of coronary events in patients with angina pectoris (AP)
|
|
|
1998 |
|
S1 |
p. 9- 1 p. |
artikel |
297 |
52 Urokinase (uPA)-mediated proteolytic and mitogenic functions in the vasculature: New facets of uPA-receptor-dependent and -independent activities
|
|
|
1998 |
|
S1 |
p. 20- 1 p. |
artikel |
298 |
Variables of the fibrinolytic system: risk indicators for CHD
|
Juhan-Vague, I. |
|
1997 |
|
S1 |
p. 47-49 3 p. |
artikel |
299 |
221 Vitamin K in the reversal of the excessive effect of anti-vitamin K drugs
|
|
|
1998 |
|
S1 |
p. 81- 1 p. |
artikel |
300 |
217 Von Willebrand factor (vWF) and tissue plasminogen activator (t-PA) as markers of endothelial hyperfunction in hyperthyroidism
|
|
|
1998 |
|
S1 |
p. 80- 1 p. |
artikel |
301 |
Which haemostatic factors should be measured in clinical practice for the prediction of coronary risk?
|
van de Loo, J.C.W. |
|
1997 |
|
S1 |
p. 163-165 3 p. |
artikel |
302 |
3 X-ray crystal structure of single chain human tPA and vampire bat plasminogen activator help to explain the activation mechanism of tPA
|
|
|
1998 |
|
S1 |
p. 3- 1 p. |
artikel |
303 |
42 XR5082 preferentially inhibits active PAI-1 which is linked to vitronectin
|
|
|
1998 |
|
S1 |
p. 16- 1 p. |
artikel |